Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,035.00    -3.50 (-0.34%)
Bid:
1,036.50
Ask:
1,037.00
Spread: 0.50 (0.048%)
Market Cap: £5.06b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Trading update

15 Jan 2021 07:00

RNS Number : 7819L
Babcock International Group PLC
15 January 2021
 

15 January 2021 

Babcock International Group PLC (Babcock or the Group)

Trading update

 

Babcock, the aerospace and defence company, issues the following trading update for the first nine months of the financial year ending 31 March 2021.

 

Group trading

Trading in the third quarter saw a continuation of trends in the first half of the year, with weakness in our civil aviation businesses and a negative impact from COVID-19.

 

Underlying revenue in the nine months year to date (YTD) was £3,399 million (9M 2020: £3,574 million), down 3% on last year excluding disposals and FX. Underlying operating profit in the nine months YTD was £202 million (9M 2020: £320 million), down 34% excluding disposals and FX, with a negative impact from civil nuclear insourcing, COVID-19 and civil aviation.

 

Order intake YTD was £3.1 billion with the Group's order book standing at £16.8 billion at 31 December 2020 (31 March 2020: £17.6 billion).

 

Balance sheet

The Group's net debt1 (excluding lease obligations) at 31 December 2020 was £1,207 million, a reduction of £255 million compared to 31 December 20192. Although this position is higher than that reported at 30 September 2020 of £871 million, it is consistent with the average net debt for the first nine months of this financial year of £1,222 million3.

 

Review of contract profitability and balance sheet

We have recently started a detailed review of our balance sheet and contract profitability. Early indications suggest that there may be negative impacts on the balance sheet and/or income statement for current and/or future years. This review is being supported by an independent accounting firm and the outputs will be reviewed by our auditor (PWC), Audit Committee and Board prior to the publication of our audited results for the year ending 31 March 2021 expected in May.

 

Outlook

Uncertainty remains around the outturn for this financial year, especially given that our fourth quarter is historically our strongest and that the COVID-19 situation has worsened in most of our markets. Given this uncertainty, and the start of our review of contract profitability and balance sheet, we continue not to provide financial guidance for this financial year.

 

Review of strategic priorities

We announced a review of the Group's strategic priorities in November 2020 and this is now well underway. Our focus throughout this review will be on cash delivery, being a strategic partner to the UK Government, international growth, driving innovation across the Group, and transforming our ESG and people agenda. We will outline our refreshed strategy alongside our full year results.

 

David Lockwood, CEO said:

"While trading in the third quarter has continued to reflect the challenges of the first half and there remain a number of near term uncertainties, the fundamental strengths of the Group and the opportunities ahead give us confidence for future years and I look forward to reporting back at the full year results".

 

 

For further information please contact:

 

Babcock International Group PLC

Simon McGough Kate Hill

Director of Investor Relations Group Director of Communications

Tel: +44 (0)7850 978 741 Tel: +44 (0)20 7355 5312

 

FTI Consulting

John Waples / Nick Hasell / Alex Le May

Tel: +44 (0)20 3727 1340

 

 

Notes

1. Net debt includes the benefit of ongoing receivables factoring and supply chain finance programmes.

2. This includes net proceeds from the sales of Context, Holdfast and Conbras of £194 million.

3. Based on the average of nine month end positions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFSEELEFSEFF
Date   Source Headline
1st Aug 20147:00 amRNSContract Award
29th Jul 20147:00 amRNSBoard Changes
21st Jul 20144:01 pmRNSResult of AGM
21st Jul 20147:00 amRNSInterim Management Statement
3rd Jul 201412:00 pmRNSHolding(s) in Company
30th Jun 20141:35 pmRNSCompletion of Acquisition
30th Jun 201410:48 amRNSTotal Voting Rights
26th Jun 20141:00 pmRNSDirector/PDMR Shareholding
25th Jun 20147:00 amRNSContract Announcement
17th Jun 20143:04 pmRNSAnnual Financial Report
13th Jun 201411:51 amRNSHolding(s) in Company
13th Jun 201410:54 amRNSDirector/PDMR Shareholding
11th Jun 20149:00 amRNSListing Application
9th Jun 20144:03 pmRNSRe Contracts
21st May 20148:59 amRNSDirector/PDMR Shareholding
19th May 20147:00 amRNSFull Year Results
16th May 201412:48 pmRNSDirector/PDMR Shareholding
16th May 201411:22 amRNSCompletion of Acquisition
12th May 20147:00 amRNSPreferred Bidder - Network Rail contract
9th May 201410:14 amRNSHolding(s) in Company
7th May 201410:46 amRNSDirector/PDMR Shareholding
7th May 201410:41 amRNSTotal Voting Rights
7th May 201410:16 amRNSResult of Rump Placing
7th May 20147:00 amRNSResults of Rights Issue
2nd May 201411:59 amRNSDirector/PDMR Shareholding
1st May 20142:07 pmRNSDirector/PDMR Shareholding
30th Apr 201411:49 amRNSHolding(s) in Company
25th Apr 20144:27 pmRNSReceipt of Regulatory Approval
24th Apr 20141:26 pmRNSDirector/PDMR Shareholding
17th Apr 20147:00 amRNSAdmission of Nil Paid Rights
16th Apr 201412:45 pmRNSEGM Statement
4th Apr 201412:08 pmRNSBlocklisting Interim Review
1st Apr 20147:00 amRNSContract Award
31st Mar 201410:30 amRNSPreferred Bidder Announcement
27th Mar 20143:42 pmRNSPublication of Prospectus
27th Mar 20147:00 amRNSAcquisition
21st Mar 201410:00 amRNSBoard Change
28th Feb 20147:02 amRNSDirector Declaration
12th Feb 201410:00 amRNSRe: Network Rail Contract
11th Feb 20147:00 amRNSInterim Management Statement
15th Jan 201412:07 pmRNSHolding(s) in Company
17th Dec 20137:00 amRNSAcquisition of Context Information Security
6th Dec 201310:00 amRNSNew Board Appointment
25th Nov 20137:00 amRNSStatement regarding Avincis
12th Nov 20137:00 amRNSHalf Yearly Report
30th Sep 20132:59 pmRNSBlocklisting Interim Review
27th Sep 20137:00 amRNSCapital Markets Seminar and Trading Update
16th Aug 20131:02 pmRNSDirector/PDMR Shareholding
14th Aug 20133:50 pmRNSDirector/PDMR Shareholding
14th Aug 20133:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.